News

02-02	OctoPlus enters into drug development and manufacturing contract with Ferring Pharmaceuticals A/S
02-02	European Medicines Agency approves Orphan Medicinal Product application of DCPrime's Acute Myeloid Leukemia vaccine
01-02	Kenniscentrum Plantenstoffen opent eerste tender
01-02	Sanofi Commits to Eliminate or Control Five Neglected Tropical Diseases
31-01	MSD/Merck Animal Health Hoofdkantoor in New Jersey, VS
31-01	TU Delft: Vici voor ontwikkelen mechanische inktvis voor hersenbasischirurgie
30-01	Call for biotech entrepeneurs: Holland pavilion at BIO International 2012
30-01	AMT announces European Commission delays decision on Glybera® marketing authorisation
27-01	Crossbeta Biosciences, Good Biomarker Sciences and U-Protein Express join forces to develop Alzheimer’s disease biomarker
27-01	FlexGen expands to new location in Nijmegen
27-01	Nationale App Prijs voor slimme toepassingen van overheidsdata
27-01	OctoPlus publishes Prospectus for listing of shares issued on 31 October 2011
27-01	Almirall and Galapagos enter research alliance
27-01	Fornix publiceert voorlopige jaarcijfers 2011
26-01	FlexGen, BGI and LUMC collaborate in Target Enrichment experiment
26-01	Philips launches new mammography solution
26-01	Almirall and Galapagos enter research alliance
26-01	New Data Published On Ruconest's Effect On Blood Clotting Parameters During HAE Attacks
26-01	Fornix publiceert voorlopige jaarcijfers 2011
26-01	OctoPlus annouces the proposal to appoint Staf van Reet to the Supervisory Board
26-01	Nieuw bedrijf combineert kennis van UMC St Radboud en MSD Oss
26-01	Promovendus:‘Verlaag de leeftijdsgrens voor borstkankerscreening’
26-01	Avantium and Rhodia to jointly develop biobased polyamides
26-01	Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates
25-01	New Data Published On Ruconest's Effect On Blood Clotting Parameters During HAE Attacks
24-01	MSD Animal Health in Publiek-Private Samenwerking voor de behandeling van Mastitis bij Runderen
24-01	AWT Rapport "Ambitious Entrepeneurship": Nog ondernemender HO, alsjeblieft
24-01	Topman CVZ kondigt modernisering aan
24-01	Genzyme Announces FDA Approval of Framingham Manufacturing Plant
24-01	Jury Pfizer Persprijs maakt genomineerde journalisten bekend
23-01	ZonMW: Toekomstbestendige ouderenzorg
23-01	Philips simplifies healthcare for care providers and patients
23-01	Radboud lanceert drie nieuwe apps voor patiënten
20-01	Prognose geneesmiddelkosten over 10 jaar
20-01	Dutch biotech company profiles in updated PDF for BIO Europe Spring 2012
20-01	UMC St. Radboud: Eierstokkanker komt uit de baarmoeder
19-01	Tweede Innovatieprestatiecontracten (IPC) tender levert ruim 50 aanvragen aanvragen op
19-01	Kijk op donderdag 19 januari naar Life Sciences in Nederland op RTL Z en RTL Nieuws
19-01	Synthon receives European approvals for Rosuvastatin
18-01	EDMA and Eucomed to establish European industry federation
18-01	Vertrouwen in life sciences & health sector: Stijging aantal bedrijven en werkgelegenheid biotech sector
18-01	Genzyme announces European Approval of Framingham
18-01	Mibiton invests in novel life sciences infrastructure
17-01	Ondernemers ‘Back to the Future’
17-01	Reference Notox publication
17-01	Handelsmissie naar Taiwan en Singapore
16-01	Bedrijfsleven investeert ruim 1,5 miljard euro in innovatie
16-01	Syncoms "Molecule of the year award" 2011
12-01	ELA’s Life Science Awards Take Centre Stage for a Second Year
12-01	InnovatiefondsMKB+ voor vernieuwende ondernemers van start
12-01	Campussen: de Zuid-Limburgse sleutels voor de toekomst
12-01	OctoPlus announces agreement with leading pharmaceutical company for development of a controlled release formulation
11-01	Agendia Appoints Peter C. Wulff as Vice President of Finance and Chief Financial Officer
10-01	Genetisch verband tussen ziekte van Parkinson en ALS
10-01	Meedenksymposium patiëntgedreven interventies: Operating the future
10-01	Be a visible part of the Dutch Pavilion at BIO Europe Spring 2012
06-01	Agendia Signs Contract with Blue Shield of California
06-01	UMC Radboud: Nieuwe erfelijke oorzaak hartfalen ontdekt
05-01	Volkskrant: MKB heeft niets aan belastingvoordelen
05-01	Thermo Fisher Scientific Now Offers Direct Purchasing to Netherlands Customers
05-01	OctoPlus announces expansion of drug delivery contract with top-5 pharmaceutical company
04-01	Amsterdam Molecular Therapeutics Receives US Orphan Designation for Hemophilia B Gene Therapy
04-01	Automatische billenbeschermer getest
04-01	Synthon obtains European approvals for Ibandronate injectable
04-01	Ronald Brus, CEO Crucell, gaat nieuw bedrijf starten
04-01	Health Valley bijeenkomst ‘From Molecule to Business’
03-01	Philips and VU University Medical Center Amsterdam sign agreement for PET/MR scanner to advance new approaches to cancer and neurology care
22-12	Proefapen MSD met vervroegd pensioen
22-12	Philips: FDA clearance and first commercial installation of HeartNavigator intervention tool in the US
22-12	Galapagos initiates clinical study with GLPG0974
22-12	OctoPlus wins drug manufacturing contract from existing client
22-12	Verbetering geneesmiddelonderzoek in Nederland
22-12	Alie Tigchelhoff benoemd tot directeur Life Sciences Park Oss
20-12	New Laboratories and offices for Life Science in Amsterdam
20-12	DSM invests in nanotechnology company NanoHoldings, LLC
20-12	Farmaceutisch bedrijf vestigt Beneluxkantoor in Breda
20-12	Pharming Announces Agreement With Renova Life Targeting Factor VIII For The Treatment Of Haemophilia A
20-12	Galapagos achieves clinical Proof-of-Mechanism milestone in GSK alliance
20-12	Galapagos increases share capital through warrant exercises
19-12	arGEN-X is awarded €1.3 million IWT Grant to Advance Proprietary SIMPLE Antibody™ Platform
19-12	to-BBB receives International Innovation grant to support partnership with top-5 pharma company
19-12	DiagnOptics receives CE mark approval for Diab-spot
15-12	Galapagos receives €4 million in milestones from Servier in their osteoarthritis alliance
15-12	Amsterdam Molecular Therapeutics Announces Negative Equity Position
14-12	Pharming Granted U.S. Patent On C1 Inhibitor Use In Ischemia Reperfusion Injury Indications
14-12	Ceronco wint Investors Forum op Dutch Life Sciences & Health Conference
14-12	Synthon filed Glatiramer acetate dossier in the US
14-12	Dutch analytical company Abundnz accelerates the development of innovative medicines
14-12	Levering en toediening van TNF-alfaremmers verandert
14-12	Tranzyme Pharma and Norgine Complete Enrolment in First of two Pivotal Phase 3 Trials of TZP-101
08-12	Bio Europe Spring information online
08-12	PwC's Diagnostics 2011
08-12	3D-PharmXchange founded and opened new offices recently
08-12	Arcarios supported by Agentschap NL to accelerate the development of its disease modifying osteoarthritis drug
08-12	Santarus And Pharming Announce Oral Presentations Of Retrospective Analyses Of Data From Rhucin Clinical Program At World Allergy Congress
08-12	VU researchers identify genes that influence platelets
08-12	Forbion Announces Closing of Second FCF 1 Co-Investment Fund
08-12	Minder sterfte borstkanker na deelname bevolkingsonderzoek
08-12	Agendia to Present Five Abstracts at 2011 San Antonio Breast Cancer Symposium
08-12	Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue